EDGAR Filing Documents for 0001176256-15-000387

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001176256-15-000387

Filing Date

2015-12-31

Accepted

2015-12-31 13:45:47

Documents

Period of Report

2015-12-22

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER FOR DECEMBER 22, 2015	nymoxPharma6k.htm	6-K	8689
2	RESPONSE LETTER FROM CUTLER & CO	exhibit99-1.htm	EX-99.1	1515
3		exhibit99-1x1x1.jpg	GRAPHIC	9047
4		exhibit99-1x1x2.jpg	GRAPHIC	2701
5		exhibit99-1x1x3.jpg	GRAPHIC	5128
	Complete submission text file	0001176256-15-000387.txt		34877

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 151315694
SIC: 2835 In Vitro & In Vivo Diagnostic Substances